Access to anti-retroviral drugs, female in Guyana
Guyana: Access to anti-retroviral drugs, female was 75.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Guyana, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Guyana stood at 75.0%. That is the highest value across all 25 years on record.
That represents a change of up 2.7% on the previous year and up 11.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Guyana peaked at 75.0% in 2019 and was at its lowest, 0.0%, in 2000.
Guyana ranks 67th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Guyana, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 3.0% | — |
| 2004 | 11.0% | +266.7% |
| 2005 | 25.0% | +127.3% |
| 2006 | 33.0% | +32.0% |
| 2007 | 39.0% | +18.2% |
| 2008 | 46.0% | +17.9% |
| 2009 | 52.0% | +13.0% |
| 2010 | 54.0% | +3.8% |
| 2011 | 59.0% | +9.3% |
| 2012 | 62.0% | +5.1% |
| 2013 | 66.0% | +6.5% |
| 2014 | 67.0% | +1.5% |
| 2015 | 69.0% | +3.0% |
| 2016 | 71.0% | +2.9% |
| 2017 | 72.0% | +1.4% |
| 2018 | 71.0% | -1.4% |
| 2019 | 75.0% | +5.6% |
| 2020 | 72.0% | -4.0% |
| 2021 | 71.0% | -1.4% |
| 2022 | 72.0% | +1.4% |
| 2023 | 73.0% | +1.4% |
| 2024 | 75.0% | +2.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 20.9% | 0.0% | 52.0% | 10 |
| 2010s | 66.6% | 54.0% | 75.0% | 10 |
| 2020s | 72.6% | 71.0% | 75.0% | 5 |
Countries ranked near Guyana
More gender data for Guyana
- Child population (UN estimates and projections) 236.01 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.7051 % change on previous year (2030)
- Population 625.02 (2030)
- Working-age population (UN estimates and projections) 625.02 (2030)
- Population (UN estimates and projections), annual growth rate 1.08 % change on previous year (2030)
- Age population, age 00, female, interpolated 7,888 (2025)
- Age population, age 00, male, interpolated 8,132 (2025)
- Age population, age 01, female, interpolated 7,912 (2025)
- Age population, age 01, male, interpolated 8,158 (2025)
- Age population, age 02, female, interpolated 7,973 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Guyana?
- Access to anti-retroviral drugs, female in Guyana was 75.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Guyana?
- The highest recorded value was 75.0% in 2019.
- What is the lowest access to anti-retroviral drugs, female recorded in Guyana?
- The lowest recorded value was 0.0% in 2000.
- How does Guyana rank for access to anti-retroviral drugs, female?
- Guyana ranks 67th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Guyana?
- Over the last ten years it is up 11.9%. The long-run trend across the full record is volatile.
- Where does this Guyana data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.